PortfoliosLab logoPortfoliosLab logo
CTAS vs. LRCX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CTAS vs. LRCX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cintas Corporation (CTAS) and Lam Research Corporation (LRCX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CTAS achieves a -5.80% return, which is significantly lower than LRCX's 114.54% return. Over the past 10 years, CTAS has underperformed LRCX with an annualized return of 23.61%, while LRCX has yielded a comparatively higher 48.23% annualized return.


CTAS

1D
-3.08%
1M
8.08%
YTD
-5.80%
6M
-5.53%
1Y
-20.40%
3Y*
14.43%
5Y*
15.92%
10Y*
23.61%

LRCX

1D
1.18%
1M
24.16%
YTD
114.54%
6M
128.79%
1Y
303.12%
3Y*
81.91%
5Y*
43.22%
10Y*
48.23%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CTAS vs. LRCX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CTAS
Cintas Corporation
-5.80%3.78%22.24%34.82%2.97%26.51%32.74%61.73%9.04%36.32%
LRCX
Lam Research Corporation
114.54%139.16%-6.84%88.63%-40.72%53.66%64.18%119.33%-24.40%76.21%

Correlation

The correlation between CTAS and LRCX is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.37

Correlation (10Y)
Calculated over the trailing 10-year period

0.41

Correlation (All Time)
Calculated using the full available price history since Mar 26, 1990

0.35

Over the past year, the correlation between CTAS and LRCX has dropped to 0.03 - well below their long-term average of 0.35, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

CTAS:

$71.72B

LRCX:

$463.20B

EPS

CTAS:

$4.75

LRCX:

$5.29

PE Ratio

CTAS:

37.08

LRCX:

69.37

PEG Ratio

CTAS:

2.60

LRCX:

5.25

PS Ratio

CTAS:

6.51

LRCX:

21.46

PB Ratio

CTAS:

14.98

LRCX:

43.76

Total Revenue (TTM)

CTAS:

$11.03B

LRCX:

$21.68B

Gross Profit (TTM)

CTAS:

$1.33B

LRCX:

$10.84B

EBITDA (TTM)

CTAS:

$2.66B

LRCX:

$6.10B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CTAS vs. LRCX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CTAS
CTAS Risk / Return Rank: 1010
Overall Rank
CTAS Sharpe Ratio Rank: 55
Sharpe Ratio Rank
CTAS Sortino Ratio Rank: 88
Sortino Ratio Rank
CTAS Omega Ratio Rank: 99
Omega Ratio Rank
CTAS Calmar Ratio Rank: 1414
Calmar Ratio Rank
CTAS Martin Ratio Rank: 1212
Martin Ratio Rank

LRCX
LRCX Risk / Return Rank: 9898
Overall Rank
LRCX Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
LRCX Sortino Ratio Rank: 9898
Sortino Ratio Rank
LRCX Omega Ratio Rank: 9797
Omega Ratio Rank
LRCX Calmar Ratio Rank: 9999
Calmar Ratio Rank
LRCX Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CTAS vs. LRCX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cintas Corporation (CTAS) and Lam Research Corporation (LRCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CTASLRCXDifference
Sharpe ratioReturn per unit of total volatility

-6.79

Sortino ratioReturn per unit of downside risk

-6.09

Omega ratioGain probability vs. loss probability

0.84

1.63

-0.78

Calmar ratioReturn relative to maximum drawdown

-0.75

15.26

-16.02

Martin ratioReturn relative to average drawdown

-1.31

51.20

-52.51

CTAS vs. LRCX - Sharpe Ratio Comparison

The current CTAS Sharpe Ratio is -1.00, which is lower than the LRCX Sharpe Ratio of 5.79. The chart below compares the historical Sharpe Ratios of CTAS and LRCX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CTAS vs. LRCX - Drawdown Comparison

The maximum CTAS drawdown since its inception was -65.32%, smaller than the maximum LRCX drawdown of -87.90%. Use the drawdown chart below to compare losses from any high point for CTAS and LRCX.


Loading charts...

Drawdown Indicators


CTASLRCXDifference

Max Drawdown

Largest peak-to-trough decline

-65.32%

-87.90%

+22.58%

Max Drawdown (1Y)

Largest decline over 1 year

-27.23%

-20.01%

-7.22%

Max Drawdown (3Y)

Largest decline over 3 years

-27.68%

-47.10%

+19.42%

Max Drawdown (5Y)

Largest decline over 5 years

-27.68%

-56.39%

+28.71%

Max Drawdown (10Y)

Largest decline over 10 years

-48.38%

-56.39%

+8.01%

Current Drawdown

Current decline from peak

-21.83%

0.00%

-21.83%

Average Drawdown

Average peak-to-trough decline

-15.04%

-28.17%

+13.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.61%

5.95%

+9.66%

Volatility

CTAS vs. LRCX - Volatility Comparison

The current volatility for Cintas Corporation (CTAS) is 8.54%, while Lam Research Corporation (LRCX) has a volatility of 21.52%. This indicates that CTAS experiences smaller price fluctuations and is considered to be less risky than LRCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CTASLRCXDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.54%

21.52%

-12.98%

Volatility (6M)

Calculated over the trailing 6-month period

15.74%

43.63%

-27.89%

Volatility (1Y)

Calculated over the trailing 1-year period

20.40%

52.78%

-32.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.60%

46.57%

-23.97%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.70%

44.92%

-18.22%

Dividends

CTAS vs. LRCX - Dividend Comparison

CTAS's dividend yield for the trailing twelve months is around 1.02%, more than LRCX's 0.28% yield.


PositionTTM20252024202320222021202020192018201720162015
CTAS
Cintas Corporation
1.02%0.89%0.80%0.83%0.93%0.77%0.99%0.95%1.22%1.04%1.15%1.15%
LRCX
Lam Research Corporation
0.28%0.57%1.19%0.95%1.53%0.78%1.04%1.54%2.79%1.01%1.28%1.36%

Financials

CTAS vs. LRCX - Financials Comparison

This section allows you to compare key financial metrics between Cintas Corporation and Lam Research Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B3.00B4.00B5.00B6.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
2.84B
5.84B
(CTAS) Total Revenue
(LRCX) Total Revenue
Values in USD except per share items

CTAS vs. LRCX - Profitability Comparison

The chart below illustrates the profitability comparison between Cintas Corporation and Lam Research Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-100.0%-50.0%0.0%50.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
-97.8%
49.8%
Portfolio components
CTAS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cintas Corporation reported a gross profit of -2.78B and revenue of 2.84B. Therefore, the gross margin over that period was -97.8%.

LRCX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lam Research Corporation reported a gross profit of 2.91B and revenue of 5.84B. Therefore, the gross margin over that period was 49.8%.

CTAS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cintas Corporation reported an operating income of 659.90M and revenue of 2.84B, resulting in an operating margin of 23.2%.

LRCX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lam Research Corporation reported an operating income of 2.05B and revenue of 5.84B, resulting in an operating margin of 35.0%.

CTAS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cintas Corporation reported a net income of 502.50M and revenue of 2.84B, resulting in a net margin of 17.7%.

LRCX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lam Research Corporation reported a net income of 1.83B and revenue of 5.84B, resulting in a net margin of 31.3%.


Frequently Asked Questions


CTAS and LRCX have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LRCX has higher volatility (21.52%) compared to CTAS (8.54%). In terms of maximum drawdown, CTAS dropped -65.32% vs LRCX's -87.90%.

LRCX currently has the higher Sharpe Ratio (5.79 vs -1.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CTAS and LRCX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer